CRNXCrinetics Pharmaceuticals Inc
Healthcare · BiotechnologyNasdaqStockMkt cap $9B
Disclosed trades
6
0 in 30d · 0 in 90d
Politicians
2
Last trade Jul 30, 2026
Buys
4
$32K at range midpoints
Sells
2
$40.5K at range midpoints
Closing price · 365 days
Nov 6, 2025 – Sep 2, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
1 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| DGilbert Ray Cisneros, Jr. | House · CA-31 | 4 | 3 | 1 | $24K | $32.5K | Jul 30, 2026 | $56.5K |
| DJosh Gottheimer | House · NJ-05 | 2 | 1 | 1 | $8K | $8K | Mar 19, 2025 | — |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| DGilbert Ray Cisneros, Jr. | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Sell | Self | $15,001 - $50,000 | — | Jul 30, 2026 | Sep 4, 202636d | Filing |
| DGilbert Ray Cisneros, Jr. | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Buy | Self | $1,001 - $15,000 | +110.0% | Mar 3, 2026 | Apr 7, 202635d | Filing |
| DGilbert Ray Cisneros, Jr. | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Buy | Self | $1,001 - $15,000 | +147.2% | Apr 17, 2025 | May 6, 202519d | Filing |
| DJosh Gottheimer | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Sell | Joint | $1,001 - $15,000 | -176.7% | Mar 19, 2025 | Apr 10, 202522d | Filing |
| DGilbert Ray Cisneros, Jr. | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Buy | Self | $1,001 - $15,000 | +122.1% | Jan 29, 2025 | Feb 11, 202513d | Filing |
| DJosh Gottheimer | CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) | Buy | Joint | $1,001 - $15,000 | +31.9% | Sep 25, 2024 | Oct 3, 20248d | Filing |
Unusual activity Estimated
- 42Hindsight movePublic Nov 6, 2024 · traded Sep 25, 2024
CRNX rose 17% in the 30 trading days after Rep. Josh Gottheimer (joint account)'s buy (hindsight)
Details
- Politician
- Josh Gottheimer
- Ticker
- CRNX
- Asset
- Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)
- Tx type
- buy
- Traded
- Sep 25, 2024
- Filed
- Oct 3, 2024
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 8
- Owner type
- joint
- Is whale
- No
- Entry date
- Sep 25, 2024
- Entry close
- 50.45
- Exit date
- Nov 6, 2024
- Exit close
- 59.16
- Forward return
- +17.3%
- Sign adjusted return
- +17.3%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Nov 6, 2024
- Method version
- 2026-11-03